BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• FDA

  FDA Approves Genentech’s Tecentriq Hybreza, the First and Only Subcutaneous Anti-PD-(L)1 Cancer Immunotherapy

  September 12, 2024

   · 

  16 min read
• News

  Cellares and Sony Announce a Joint Development Collaboration to Integrate Flow Cytometry-Based Sorting and Online Analysis into an Automated, High-Throughput Cell Therapy Manufacturing Platform

  September 12, 2024

   · 

  7 min read
• Drug Development

  OmRx Oncology Launches to Advance Investigational Oral Checkpoint Inhibitor Designed to Increase Access to Cancer Immunotherapy Worldwide

  September 12, 2024

   · 

  3 min read
• Press Releases

  FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology

  September 12, 2024

   · 

  4 min read
• 

  Press Releases

  Allergy Diagnostics and Therapeutics Market Size is Expanding around US$ 66.60 Billion by 2033

  September 12, 2024

   · 

  11 min read
• Press Releases

  Neuspera Medical, Inc. Welcomes Bunty Banerjee as Its First Chief Operating Officer

  September 12, 2024

   · 

  3 min read
• Press Releases

  CNS Pharmaceuticals Regains Compliance with Nasdaq Equity Requirement

  September 12, 2024

   · 

  2 min read
• Business

  Immuno-Oncology Researchers Have Leveraged $200,000 in Seed Grant Funding from Curebound to Secure $9.6M in NIH Follow-On Funding and Launch Clinical Trial for Head and Neck Cancer Immunotherapy

  September 12, 2024

   · 

  3 min read
• Business

  EGLE Therapeutics Strengthens its Board of Directors with the Appointment of Michel Detheux, Ph.D., as Independent Chairman Board Member, and with the Appointment of Mojgan Hossein-Nia, Ph.D. as Board Member Representative of Takeda Ventures

  September 12, 2024

   · 

  3 min read
• FDA

  Alio Launches Calibration and Validation (CAVA) Study to Expand Alio Platform’s FDA Clearance Beyond the Vascular Access for Use in a Broader Range of Patients

  September 12, 2024

   · 

  3 min read